DIVERSIFIED HEALTHCARE TRUST
DHCUS売上高
$1.5B
百万USD
営業利益
-
百万USD
純利益
$-286M
百万USD
ROE
-17.2%
最新FY
EPS
$-1.19
USD / 株
配当
-
USD / 株
業績推移
収益性
キャッシュフロー
財務状況
四半期業績
| 年度 | 期 | 売上高 | 純利益 | EPS |
|---|---|---|---|---|
| FY2021 | Q1 | $363M | $-68M | - |
| FY2021 | Q2 | $346M | $-34M | $-0.14 |
| FY2021 | Q3 | $337M | $-89M | $-0.38 |
| FY2021 | FY | $1.4B | $175M | $0.73 |
| FY2022 | Q1 | $311M | $240M | $1.01 |
| FY2022 | Q2 | $313M | $-109M | $-0.46 |
| FY2022 | Q3 | $323M | $-81M | $-0.34 |
| FY2022 | FY | $1.3B | $-16M | $-0.07 |
| FY2023 | Q1 | $346M | $-53M | $-0.22 |
| FY2023 | Q2 | $346M | $-73M | $-0.30 |
| FY2023 | Q3 | $357M | $-66M | $-0.28 |
| FY2023 | FY | $1.4B | $-294M | $-1.23 |
| FY2024 | Q1 | $371M | $-86M | $-0.36 |
| FY2024 | Q2 | $371M | $-98M | $-0.41 |
| FY2024 | Q3 | $374M | $-99M | $-0.41 |
| FY2024 | FY | $1.5B | $-370M | $-1.55 |
| FY2025 | Q1 | $387M | $-9M | $-0.04 |
| FY2025 | Q2 | $383M | $-92M | $-0.38 |
| FY2025 | Q3 | $389M | $-164M | $-0.68 |
| FY2025 | FY | $1.5B | $-286M | $-1.19 |
| FY2026 | Q1 | $366M | $-43M | $-0.18 |
財務データ
| 指標 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| 売上高 | - | - | $1.1B | $1.0B | $1.6B | $1.4B | $1.3B | $1.4B | $1.5B | $1.5B |
| 営業利益 | $303M | $275M | - | - | - | - | - | - | - | - |
| 純利益 | $141M | $148M | $287M | $-88M | $-139M | $175M | $-16M | $-294M | $-370M | $-286M |
| 総資産 | $7.2B | $7.3B | $7.2B | $6.7B | $6.5B | $6.6B | $6.0B | $5.4B | $5.1B | $4.4B |
| 純資産 | - | $3.3B | $3.2B | $2.9B | $2.6B | $2.7B | $2.6B | $2.3B | $2.0B | $1.7B |
| 自己資本 | $3.2B | $3.1B | $3.0B | $2.7B | $2.5B | $2.7B | - | $2.3B | $2.0B | $1.7B |
| 営業CF | $427M | $407M | $393M | $266M | $159M | $-63M | $-40M | $10M | $112M | $-20M |
| EPS | - | - | - | - | - | $0.73 | $-0.07 | $-1.23 | $-1.55 | $-1.19 |
| BPS | $13.47 | $13.07 | $12.72 | $11.50 | $10.47 | $11.14 | - | $9.72 | $8.12 | $6.88 |
| ROE | 4.4% | 4.8% | 9.5% | -3.2% | -5.6% | 6.6% | - | -12.6% | -18.9% | -17.2% |